Illustration: Rebecca Zisser/Axios

Some of the researchers who helped develop a new heart-failure drug are criticizing its high price, Bloomberg reports.

The intrigue: Pfizer, which makes the drug, says that it's targeted at a small population, justifying the high price. But critics say that the condition isn't that rare, setting up Pfizer to reap in a fortune from the medication.

  • One of the researchers now criticizing the cost of the drug, tafamidis, released a cost analysis last week that found the drug is only cost-effective after a 90% price decrease.
  • Today, the drug costs $225,000 a year, or $651 per day. Four doctors involved in its clinical trials told Bloomberg that not only could it end up being given to more patients than anticipated, but that it will also be taken by patients for years or even decades.
  • However, its price tag is comparable to curative drugs or those that treat rarer diseases.

Between the lines: "While criticism of drugmakers by patients and politicians is common, it's far rarer for academics who helped lead development of a therapy to turn into antagonists of the same company that funded the research," Bloomberg's Emma Court writes.

The other side: Pfizer said the cost is appropriate and that it may be reduced if the drug is more widely used than expected.

Go deeper:

Go deeper

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Fauci: Trump hasn't been to a COVID task force meeting in months — Trump claims COVID "will go away" during debate.
  2. Sports: The youth sports exodus continues — Big Ten football is back.
  3. Health: How to help save 130,000 livesFDA approves Gilead's remdesivir as treatment How the pandemic might endMany U.S. deaths were avoidable.
  4. Retail: Santa won't greet kids at Macy's this year.
  5. World: Spain and France exceed 1 million cases.
1 hour ago - Health

Fauci: Trump hasn't been to a COVID task force meeting in months

Photo: Drew Angerer/Getty Images

President Trump has not attended a White House coronavirus task force meeting in “several months,” NIAID director Anthony Fauci told MSNBC on Friday.

Why it matters: At the beginning of the pandemic, the task force, led by Vice President Mike Pence, met every day, but in the "last several weeks," members have held virtual meetings once a week, Fauci said, even as the number of new cases continues to surge in the country.

2 hours ago - Health

How to help save 130,000 lives

People wear face masks outside Grand Central Terminal in New York City. Photo: Noam Galai/Getty Images

Nearly 130,000 fewer people will die of COVID-19 this winter if 95% of Americans wear face masks in public, according to research published Friday.

Why it matters: “Increasing mask use is one of the best strategies that we have right now to delay the imposition of social distancing mandates," Dr. Christopher Murray of the University of Washington told the N.Y. Times.